HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sporadic late-onset nemaline myopathy effectively treated by melphalan and stem cell transplant.

AuthorsN C Voermans, M Minnema, M Lammens, H J Schelhaas, A V D Kooi, H M Lokhorst, B G van Engelen
JournalNeurology (Neurology) Vol. 71 Issue 7 Pg. 532-4 (Aug 12 2008) ISSN: 1526-632X [Electronic] United States
PMID18565829 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Myeloablative Agonists
  • Melphalan
Topics
  • Adult
  • Diagnosis, Differential
  • Humans
  • Male
  • Melphalan (therapeutic use)
  • Motor Neuron Disease (physiopathology)
  • Myeloablative Agonists (therapeutic use)
  • Myopathies, Nemaline (complications, physiopathology, therapy)
  • Myositis (physiopathology)
  • Paraproteinemias (complications)
  • Stem Cell Transplantation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: